首页> 外文期刊>Cancer epidemiology, biomarkers and prevention: A publication of the American Association for Cancer Research >A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens.
【24h】

A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens.

机译:对检测SV40 DNA的检测方法进行多中心评估,并得出被屏蔽的间皮瘤标本。

获取原文
获取原文并翻译 | 示例
           

摘要

This nine-laboratory multicenter investigation was designed to assess the sensitivity, specificity, and reproducibility of previously described assays for detection of SV40 DNA with three goals, i.e., (a) to compare methods for testing human tissues, (b) to examine the ability of these methods to detect SV40 in human mesotheliomas, and (c) to uncover assay differences that could explain conflicting findings in some past investigations. Each laboratory received, in a masked fashion, paired replicate DNA samples extracted from 25 fresh frozen mesotheliomas (50 samples) and one from each of 25 normal human lungs. Interspersed were masked positive (titrations of the SV40 genome) and negative control samples. Preliminary studies confirmed the adequacy of the samples for testing high molecular weight double-stranded linear DNA targets. All 15 PCR-based assays detected 5,000 copies or less of the SV40 genome spiked into 2 microg of WI-38 DNA. A high level of specificity and reproducibility was found among the PCR assays performed in most laboratories. However, none of the selected normal human lung tissue or the 25 mesothelioma tumor specimens obtained from archival samples at a single center was reproducibly positive for the presence of SV40 DNA. Further studies are needed to reconcile these results with previous reports of detection of SV40 DNA in tumor specimens.
机译:这项由9个实验室组成的多中心研究旨在评估上述检测SV40 DNA的检测方法的敏感性,特异性和可重复性,其目标是三个,即(a)比较检测人体组织的方法,(b)检查能力这些方法来检测人间皮瘤中的SV40,以及(c)揭示可能解释某些过去研究中相互矛盾的发现的测定差异。每个实验室都以遮罩的方式接收从25个新鲜的冷冻间皮瘤(50个样品)和25个正常人肺中的每个肺中提取的成对重复DNA样品。散布的是掩蔽的阳性(SV40基因组的滴定)和阴性对照样品。初步研究证实,这些样品可用于测试高分子量双链线性DNA靶标。所有15种基于PCR的检测均检测到5,000份或更少的SV40基因组掺入2微克WI-38 DNA中。在大多数实验室中进行的PCR分析中发现了高水平的特异性和可重复性。但是,从单个中心的存档样本获得的所选正常人肺组织或25个间皮瘤肿瘤样本中,没有一个可重复显示SV40 DNA的阳性。需要进一步的研究以使这些结果与以前在肿瘤标本中检测到SV40 DNA的报道相一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号